Wiley Bros. Aintree Capital, LLC T2 Biosystems, Inc. Transaction History

Wiley Bros. Aintree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 10, 2020	SELL	$0.96 - $2.94 $24,000 - $73,500	-25,000 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$0.58 - $3.01 $14,499 - $75,250	25,000 New	25,000 $63,000
Q3 2019 Oct 04, 2019	SELL	$0.58 - $3.01 $14,499 - $75,250	-25,000 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$1.47 - $3.16 $22,050 - $47,400	15,000 Added 150.0%	25,000 $42,000
Q1 2019 Apr 08, 2019	BUY	$2.56 - $4.48 $25,600 - $44,800	10,000 New	10,000 $26,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.38M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.